FDA Approves Merck蘑菇视频 KEYTRUDA庐 (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

TAGGED : cancer

Sigma Gamma Rho Sorority, Inc. becomes first Divine Nine sorority to raise $1 million for St. Jude Children’s Research Hospital

November 3, 2023

MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov 3, 2023--<a ...

Sonata Therapeutics Presents Data Supporting its Network Medicines鈩� Approach at SITC 2023

November 3, 2023

WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 3, 2023--<a ...

Onchilles Pharma Presents at SITC 2023 New Preclinical Data for N17350, a Potential Pan-Cancer Therapeutic

November 3, 2023

SAN DIEGO--(BUSINESS WIRE)--Nov 3, 2023--<a ...

Del Grande Dealer Group Partners with Hyundai Hope On Wheels庐 to Present Funds to Lucile Packard Children蘑菇视频 Hospital to Further the Fight Against Pediatric Cancer

November 3, 2023

SAN JOSE, Calif.--(BUSINESS WIRE)--Nov 3, 2023--Del Grande Dealer Group ( <a ...

GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023

November 3, 2023

ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 3, 2023--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial results and highlights for the third quarter ...

Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx庐-UM That Could Aid in the Early Detection of Uveal Melanomas

November 3, 2023

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Nov 3, 2023--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new discovery data from an ongoing study exploring the potential for developing a complementary, minimally ...